vs
Astrana Health, Inc.（ASTH）与奇富科技（QFIN）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是奇富科技的1.3倍（$950.5M vs $731.2M），奇富科技净利率更高（27.5% vs 0.7%，领先26.8%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 16.4%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
奇富科技（原360数科）是中国头部金融科技企业，主要为持牌金融机构提供智能风控、信贷技术解决方案，服务广大个人消费者及中小微企业，依托大数据、人工智能技术提升金融服务的普惠性与运营效率。
ASTH vs QFIN — 直观对比
营收规模更大
ASTH
是对方的1.3倍
$731.2M
净利率更高
QFIN
高出26.8%
0.7%
两年增速更快
ASTH
近两年复合增速
16.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $731.2M |
| 净利润 | $6.6M | $201.2M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 32.7% |
| 净利率 | 0.7% | 27.5% |
| 营收同比 | 42.9% | — |
| 净利润同比 | 184.4% | — |
| 每股收益（稀释后） | $0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHQFIN
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $731.2M | ||
| Q2 25 | $654.8M | $728.1M | ||
| Q1 25 | $620.4M | $646.4M | ||
| Q4 24 | $665.2M | — | ||
| Q3 24 | $478.7M | $622.7M | ||
| Q2 24 | $486.3M | $572.4M | ||
| Q1 24 | $404.4M | $575.2M |
净利润ASTHQFIN
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $201.2M | ||
| Q2 25 | $9.4M | $241.6M | ||
| Q1 25 | $6.7M | $247.6M | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $256.3M | ||
| Q2 24 | $19.2M | $189.4M | ||
| Q1 24 | $14.8M | $160.7M |
营业利润率ASTHQFIN
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 32.7% | ||
| Q2 25 | 3.1% | 41.0% | ||
| Q1 25 | 3.3% | 42.1% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | 52.4% | ||
| Q2 24 | 6.2% | 47.7% | ||
| Q1 24 | 7.5% | 32.8% |
净利率ASTHQFIN
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 27.5% | ||
| Q2 25 | 1.4% | 33.2% | ||
| Q1 25 | 1.1% | 38.3% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 41.2% | ||
| Q2 24 | 3.9% | 33.1% | ||
| Q1 24 | 3.7% | 27.9% |
每股收益（稀释后）ASTHQFIN
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $6.5B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $24.3B |
| 总资产 | $2.2B | $61.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHQFIN
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $6.5B | ||
| Q2 25 | $342.1M | $5.3B | ||
| Q1 25 | $260.9M | $8.6B | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | $4.3B | ||
| Q2 24 | $327.7M | $6.3B | ||
| Q1 24 | $337.3M | $5.3B |
股东权益ASTHQFIN
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $24.3B | ||
| Q2 25 | $765.5M | $24.1B | ||
| Q1 25 | $745.4M | $23.1B | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | $22.9B | ||
| Q2 24 | $678.9M | $22.6B | ||
| Q1 24 | $653.5M | $22.1B |
总资产ASTHQFIN
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $61.4B | ||
| Q2 25 | $1.4B | $59.8B | ||
| Q1 25 | $1.3B | $55.6B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | $47.0B | ||
| Q2 24 | $1.3B | $47.0B | ||
| Q1 24 | $1.2B | $47.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $351.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 1.75× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHQFIN
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $351.4M | ||
| Q2 25 | $90.9M | $366.0M | ||
| Q1 25 | $16.6M | $386.6M | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | $338.0M | ||
| Q2 24 | $23.2M | $269.9M | ||
| Q1 24 | $6.0M | $271.2M |
自由现金流ASTHQFIN
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHQFIN
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHQFIN
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHQFIN
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 1.75× | ||
| Q2 25 | 9.65× | 1.52× | ||
| Q1 25 | 2.48× | 1.56× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.32× | ||
| Q2 24 | 1.21× | 1.43× | ||
| Q1 24 | 0.40× | 1.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
QFIN
暂无分部数据
